Sun Pharma Advanced Research Company Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sun Pharma Advanced Research Company Limited generated cash of -$4,291,883,000, which is less than the previous year. Cash used in financing activities reached the amount of $424,051,000 last year. Net change in cash is therefore $47,459,000.
Cash Flow
| 2010 | 126.34M | -121.68M | 2.79M |
|---|---|---|---|
| 2011 | 25.04M | -75.57M | 41.22M |
| 2012 | -694.48M | -24.24M | 721.04M |
| 2016 | -442.11M | -130.79M | 505.47M |
| 2018 | -1.82B | -1.04B | 2.24B |
| 2020 | -2.10B | 1.55B | 554.61M |
| 2021 | -1.51B | 15.61M | 1.59B |
| 2023 | -691.2M | -5.48B | 6.16B |
| 2024 | -4.29B | 3.91B | 424.05M |
SPARC.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.83M | 12.2M | 3.52M | 3.49M | 635.83M | 106.34M | 3.35M | 12.65M | 5.20M |
Operating activities | |||||||||
Net income | -3.87B | -2.22B | -1.51B | -3.12B | -2.45B | -699.92M | -722.32M | -85.00M | -215.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 125.10M | 117.7M | 109.23M | 94.80M | 81.84M | 75.78M | 31.62M | 29.85M | 25.99M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 152.14M | -50.06M | -15.43M | -58.31M | 213.44M | 107.57M | 0 | 0 | 0 |
Inventories | 0 | 19K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -58.9M | 766.67M | -601.75M | 717.75M | 77.23M | 311.06M | 0 | 0 | 0 |
Cash generated by operating activities | -4.29B | -691.2M | -1.51B | -2.10B | -1.82B | -442.11M | -694.48M | 25.04M | 126.34M |
Investing activities | |||||||||
Purchases Of Investments | -250M | -10.55B | -50K | -1.04M | -5.66B | -234.78M | -340.16M | -111M | -40.85M |
Investments In Property Plant And Equipment | -265.07M | -153.9M | -59.95M | -540.42M | -326.30M | -123.28M | 0 | -47.34M | -81.83M |
Acquisitions Net | 4.85M | 23.40M | -55K | 540.42M | 149.47M | 12.35M | 0 | 0 | 0 |
Cash generated by investing activities | 3.91B | -5.48B | 15.61M | 1.55B | -1.04B | -130.79M | -24.24M | -75.57M | -121.68M |
Financing activities | |||||||||
Common Stock Issued | 0 | 7.02B | 0 | 0 | 2.25B | 19.96M | 110M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -119K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 469.49M | -749.49M | -2.37B | 574.25M | -8.52M | 515.35M | -11.5M | 0 | -17.18M |
Cash used in financing activities | 424.05M | 6.16B | 1.59B | 554.61M | 2.24B | 505.47M | 721.04M | 41.22M | 2.79M |
Net Change In Cash | 47.45M | -6.4M | 89.52M | 27K | -633.80M | -66.34M | 2.37M | -9.30M | 7.45M |
Cash at end of period | 53.29M | 5.8M | 93.04M | 3.52M | 2.03M | 40.00M | 5.73M | 3.35M | 12.65M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |